| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Executive Officer | EVP, Chief Commercial Officer
2 companies
Boerner Christopher S. is a Chief Executive Officer at CELG-RI with holdings across 2 companies. Recent SEC Form 4 filings include 3 buys and 1 sell.
Estimated insider holdings value: $167K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb 20, 2025 | BMY Bristol Myers Squibb Co | Chief Executive Officer | Buy | 2,000 | $55.05 | $110,096.00 | +1.9% | -15.8% | +8.7% | |
| Dec 5, 2023 | BMY Bristol Myers Squibb Co | Chief Executive Officer | Buy | 2,000 | $49.78 | $99,560.00 | +2.5% | +1.4% | +16.2% | |
| Nov 28, 2023 | BMY Bristol Myers Squibb Co | Chief Executive Officer | Buy | 3,071 | $48.86 | $150,049.06 | +4.0% | +3.3% | +21.2% | |
| Mar 14, 2022 | BMY Bristol Myers Squibb Co | EVP, Chief Commercial Officer | Sell | 29,532 | $69.20 | $2,043,525.80 | -41.3% | +7.1% | -1.9% |